FDA approves Eli Lilly’s Mounjaro to reduce the risk of heart attack & stroke in high-risk adults with type 2 diabetes.
FDA approves Eli Lilly’s Mounjaro to reduce the risk of heart attack & stroke in high-risk adults with type 2 diabetes.
News sentiment80 · Strongly bullish
Market impact60/100
Event statedeveloping
The headline is open. The market meaning goes deeper.
Preview the analysis BORSA members receive around every material canonical event.
BORSAPLUSUnlock the intelligence behind the signal.
Create free account · 3 views/day